|
Cancer Center Support Grant
|
5P30CA082103-13
|
$7,206,672
|
$144,133
|
MCCORMICK, FRANK
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Regional Oncology Research Center
|
3P30CA006973-48S3
|
$6,995,274
|
$69,953
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
2P30CA014089-36
|
$6,160,984
|
$61,610
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Cancer Center Support Grant
|
5P30CA091842-10
|
$4,380,520
|
$87,610
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Growth Control in Multiple Myeloma
|
5P01CA055819-17
|
$3,653,305
|
$365,331
|
BARLOGIE, BART
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
The Immunobiology of Marrow Allografts for Leukemia
|
5P01CA023766-33
|
$3,002,066
|
$150,103
|
O'REILLY, Richard
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
ZIA SC 004020
|
$2,586,956
|
$258,695
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Eastern Cooperative Group Chair's Office
|
3U10CA086802-13S1
|
$2,561,235
|
$128,062
|
COMIS, ROBERT
|
DREXEL UNIVERSITY
|
|
University of Rochester Cancer Center CCOP Research Base
|
5U10CA037420-27
|
$2,137,632
|
$128,258
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-33
|
$1,795,225
|
$17,952
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
2P30CA134274-04
|
$1,565,163
|
$46,955
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-27
|
$1,400,911
|
$14,009
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
Protein Structure
|
ZIA BC 010348
|
$1,178,370
|
$176,755
|
Wlodawer, Alexander
|
CCR (NCI)
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-25
|
$1,147,220
|
$11,472
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
5P30CA082709-13
|
$1,145,097
|
$11,451
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Role of inflammation, innate resistance, and immunity in carcinogenesis.
|
ZIA BC 010793
|
$987,874
|
$197,574
|
Trinchieri, Giorgio
|
CCR (NCI)
|
|
Pathogenic Effects of Human Retroviruses on Hematopoietic and Adherent Cells.
|
ZIA BC 010252
|
$948,048
|
$189,609
|
Ruscetti, Francis
|
CCR (NCI)
|
|
TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035415-28
|
$797,203
|
$15,944
|
MOWAT, REX
|
TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
|
|
Phase I Trials of Anti-Cancer Agents
|
5U01CA076576-14
|
$739,271
|
$81,320
|
GREVER, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Illinois Oncology Research Association Community Clinical Oncology Program
|
5U10CA035113-28
|
$732,293
|
$14,646
|
Le-Lindqwister, Nguyet
|
ONCOLOGY-HEMATOLOGY ASSOC-CENTRAL ILL
|
|
Ochsner Community Clinical Oncology Program
|
2U10CA035272-27A1
|
$698,610
|
$13,972
|
FULORIA, JYOTSNA
|
OCHSNER CLINIC FOUNDATION
|
|
Kansas City Clincal Oncology Program CCOP
|
2U10CA035176-27A1
|
$650,000
|
$6,500
|
GAUR, RAKESH
|
KANSAS CITY CLINICAL ONCOLOGY PROGRAM
|
|
Eastern Cooperative Group Chair's Office
|
5U10CA086802-13
|
$629,400
|
$31,470
|
COMIS, ROBERT
|
DREXEL UNIVERSITY
|
|
Control of Cytokine Gene Expression in Lymphoid/Myeloid Cells
|
ZIA BC 009283
|
$617,430
|
$617,429
|
Young, Howard
|
CCR (NCI)
|
|
Signal Transduction Events and the Regulation of Cell Growth
|
ZIC SC 006743
|
$611,794
|
$61,179
|
Trepel, Jane
|
CCR (NCI)
|
|
North Shore CCOP
|
5U10CA035279-28
|
$599,459
|
$5,995
|
VINCIGUERRA, VINCENT
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
|
Ozark Health Ventures, LLC dba Cancer Research for the Ozarks
|
5U10CA045560-23
|
$589,085
|
$5,891
|
Carolla, Robert
|
OZARK HEALTH VENTURES, LLC
|
|
MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA045564-25
|
$572,575
|
$5,726
|
Schwartz, Michael
|
MOUNT SINAI MEDICAL CENTER (MIAMI BEACH)
|
|
Virginia Mason Community Clinical Oncology Program
|
2U10CA035192-27A1
|
$569,700
|
$5,697
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Immune reconstitution following autologous and allogeneic stem cell transplant
|
ZIC BC 010934
|
$550,354
|
$165,106
|
Hakim, Frances
|
CCR (NCI)
|
|
Kalamazoo Community Clinical Oncology Program
|
5U10CA035184-27
|
$535,888
|
$10,718
|
LORD, RAYMOND
|
WEST MICHIGAN CANCER CENTER
|
|
A HER-2/neu pulsed DC1 vaccine for patients with DCIS
|
5R01CA096997-06
|
$503,290
|
$25,165
|
CZERNIECKI, BRIAN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Developing new immunotherapies based of CD4+ T cells
|
ZIA BC 011037
|
$502,734
|
$50,273
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Pathogenesis of EBV Infection
|
5R01CA068051-16
|
$454,973
|
$22,749
|
WANG, FREDERICK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The connection of innate and adaptive anti-cancer immunity
|
ZIA BC 010970
|
$451,369
|
$361,095
|
Greiner, John
|
CCR (NCI)
|
|
T Cell Immunity in Endemic Burkitt Lymphoma
|
5R01CA134051-05
|
$450,184
|
$225,092
|
MOORMANN, ANN
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Community Clinical Oncology Program: FL Pediatric CCOP
|
5U10CA035157-28
|
$450,001
|
$4,500
|
TALBERT, JAMES
|
FLORIDA ASSN OF PEDIATRIC TUMOR PROG
|
|
IP-10 Chemokine: Its Role in T Cell Recruitment and Disease
|
5R01CA069212-15
|
$383,924
|
$191,962
|
LUSTER, ANDREW
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
THE ROLE OF THE INTERFERONS IN CANCER IMMUNOEDITING
|
5R01CA043059-23
|
$357,864
|
$357,864
|
SCHREIBER, ROBERT
|
WASHINGTON UNIVERSITY
|
|
MOLECULAR MECHANISMS OF TUMOR-INDUCED TOLERANCE
|
7R01CA097085-10
|
$355,772
|
$35,577
|
Chen, Lieping
|
YALE UNIVERSITY
|
|
Southwest Oncology Group
|
5U10CA011083-44
|
$355,653
|
$21,339
|
FRIEDBERG, JONATHAN
|
UNIVERSITY OF ROCHESTER
|
|
ST Louis-Cape Girardeau CCOP
|
5U10CA035128-28
|
$346,462
|
$3,465
|
Sleckman, Bethany
|
ST. JOHN'S MERCY MEDICAL CENTER
|
|
Role of microRNAs in Regulating Gene Expression
|
ZIA BC 011149
|
$332,462
|
$332,462
|
Young, Howard
|
CCR (NCI)
|
|
Modulation of IFN action via novel regulatory factors
|
5R01CA078282-12
|
$319,724
|
$319,724
|
KALVAKOLANU, DHAN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Cancer immunotherapy with a live recombinant vaccine
|
5R01CA069632-13
|
$317,115
|
$79,279
|
PATERSON, YVONNE
|
UNIVERSITY OF PENNSYLVANIA
|
|
T Cell Alternative p38 Activation Pathway
|
ZIA BC 010774
|
$312,671
|
$78,167
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Molecular Basis of Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis
|
5R01CA082057-13
|
$312,161
|
$312,161
|
JUNG, JAE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Oncolytic Virus Targets Brain Tumors
|
5R01CA124737-05
|
$305,017
|
$152,509
|
VAN DEN POL, ANTHONY
|
YALE UNIVERSITY
|
|
Activating robust immunity to tumor-associated antigens:mechanisms and biology
|
5R01CA138617-03
|
$301,913
|
$301,913
|
Janssen, Edith
|
CHILDREN'S HOSPITAL MEDICAL CENTER CINCI
|
|
Immunological Modulation of Ocular Tumor Metastases
|
5R01CA030276-30
|
$278,621
|
$55,724
|
NIEDERKORN, JERRY
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
Total relevant funding to Interferon for this search: $7,337,825
|